Company family · public contract awards
C.H. Boehringer Sohn public contracts. C.H. Boehringer Sohn is a family of 4 companies that won 507 public contracts in 4 countries, headed by C.H. Boehringer Sohn AG & Co. KG (Germany). Its companies' largest customer is Amgros I/S (79 contracts). Latest award: Jul 2026.
507 Contracts won
4 Companies
4 Countries
Jul 2026 Latest award
Latest contracts won Spanyolország – Gyógyszerészeti termékek – ALMERIA 2º CBAM CONTR 2026 0000642291_2 14 Jul 2026Awarded
Spanyolország – Különböző gyógyszerek – suministro del principio activo denominado "TENECTEPLASA 5.000 U VIAL" para el Hospital Universitariode Gran C 4 Jun 2026Awarded
Dánia – Gyógyszerészeti termékek – Amgros 2026 1.211.a 14 Apr 2026Awarded
Arzneimittelvergaben zum 01.01.2026 und 01.07.2026 3 Mar 2026Awarded
Spanyolország – Gyógyszerészeti termékek – FÁRMACOS EXCLUSIVOS 21 Jan 2026Awarded
Spanyolország – Gyógyszerészeti termékek – Suministro de Afatinib (DOE) 19 Jan 2026Awarded
Spanyolország – Immunszuppresszív szerek – suministro de Medicamentos exclusivos con principios activos Espesolimab, Tiotropio bromuro,Llinagliptina, 13 Nov 2025Awarded
Spanyolország – Gyógyszerészeti termékek – Suministro de Alteplasa (DOE) y Tenecteplasa (DOE) 6 Jun 2025Awarded
Spanyolország – Gyógyszerészeti termékek – EXP. 2024-104 Suministro de medicamentos diversos II con destino el Hospital Clínic de Barcelona (HCB). 15 Apr 2025Awarded
Arzneimittelvergaben zum 01.01.2025 und 01.07.2025 15 Apr 2025Awarded
Spanyolország – Gyógyszerészeti termékek – Suministro de Nintedanib (DOE) e Idarucizumab (DOE) 5 Feb 2025Awarded
Arzneimittelvergaben zum 01.01.2025 und 01.07.2025 14 Nov 2024Awarded
Suministro de diversos medicamentos exclusivos con destino a los centros sanitarios dependientes de la Gerencia Regional de Salud de Castilla y León 19 Sep 2024Awarded
Suministro de Alteplasa 20 mg inyectable, Alteplasa 50 mg inyectable, Tenecteplasa 8.000 U inyectable y Tenecteplasa 10.000 U inyectable, medicamentos 17 Jul 2024Awarded
Arzneimittelvergaben zum 1.Juli 2024 9 Jul 2024Awarded
Arzneimittelrabattverträge gem. § 130a Abs. 8 SGB V im Rahmen von Open-House-Verfahren 17 Nov 2023Awarded
Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130a Abs. 8 SGB V zu Fertigarzneimitteln mit dem Wirkstoff Tiotropium (INL) 30 Aug 2023Awarded
Aufhebung Open house Verfahren Arzneimittelrabattverträge Dabigatranetexilat, ATC B01AE07 14 Jul 2023Awarded
Contracts won by year Contracts won by year
from the published records 2015 11
2016 17
2017 17
2018 28
2019 33
2020 24
2021 18
2022 14
2023 24
2024 7
2025 7
2026 7
Published value, by currency DKK · 19 valued
DKK 310 million
EUR · 4 valued
€2.19 million
The family adds up the public contract awards of every company below. Who belongs to the family comes from GLEIF, the global register of legal entities (Legal Entity Identifier 529900P5FAANZASUYL28, accounting consolidation); 1 company was matched by registry number and the rest by exact legal name in their country. Each currency is shown on its own and never converted.
Companies in the family By country Main buyers Bid with askTender
Bidding against C.H. Boehringer Sohn? askTender reads any open tender against your company profile — eligibility, the gaps, and the documents you need — and can prepare the entire bid.
askTender ↗ See open tenders